Antibodies

The presence of serum anti-SARS-CoV-2 IgA appears toprotect primary health care workers from COVID-19

Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine

Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies

Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape

Protective immunity after recovery from SAR-CoV-2 infection

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

This ‘super antibody’ for COVID fights off multiple coronaviruses

Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies

Long-Term Persistence of IgG Antibodies in recovered COVID-19 individuals at 18 months and the impact of two-dose BNT162b2 (Pfizer-BioNTech) mRNA vaccination on the antibody response

Antibody Evolution after SARS-CoV-2 mRNA Vaccination